MTM(SH:688029) Xin Lang Cai Jing·2025-11-11 06:06Core Viewpoint - Nanwei Medical's stock has shown a significant increase of 27.99% year-to-date, with a recent trading price of 84.60 CNY per share, indicating strong market interest and performance in the medical device sector [1][2]. Financial Performance - For the period from January to September 2025, Nanwei Medical achieved a revenue of 2.381 billion CNY, representing a year-on-year growth of 18.29%. The net profit attributable to shareholders was 509 million CNY, reflecting a growth of 12.90% [2]. - Cumulative cash dividends since the company's A-share listing amount to 978 million CNY, with 664 million CNY distributed over the past three years [3]. Stock Market Activity - As of November 11, the stock price of Nanwei Medical increased by 2.00% during trading, with a total market capitalization of 15.892 billion CNY. The trading volume reached 113 million CNY, with a turnover rate of 0.72% [1]. - The stock has experienced a recent net inflow of 2.881 million CNY from major funds, indicating positive investor sentiment [1]. Shareholder Structure - As of September 30, 2025, the number of shareholders increased to 12,500, with an average of 15,009 circulating shares per person, a decrease of 1.36% from the previous period [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the fifth largest with 3.6594 million shares, marking its entry as a new shareholder [3].